Wales has begun the rolled-out of a community pharmacy prescribing service as part of reforms agreed by the Welsh health minister last December.
Eluned Morgan approved wide-ranging changes following re-negotiation of the Community Pharmacy Contractual Framework with Community Pharmacy Wales, the
representative body for community pharmacies in Wales.
The roll out will allow appropriately trained community pharmacists to treat an extended range of conditions that currently require people to visit their GP.
Initially pharmacist prescribers will be able to prescribe medicines, including antibiotics for acute illnesses like urinary tract and upper respiratory tract infections, and also prescribe routine contraception.
The first of its kind in the UK, the service is being rolled out progressively across Wales, building on local schemes which are already in place.
The Royal Pharmaceutical Society (RPS) Wales has welcomed proposals from the Welsh government to increase access to PrEP via community pharmacies for people at
risk of HIV.
The new HIV Action Plan for Wales consultation proposes a shared care model between primary care and specialist sexual health services to improve access to PrEP.
Commenting on the proposal, chair of RPS in Wales Cheryl Way said: "Increasing access to the medicines has been a long-standing issue of concern for us at RPS and
we're therefore delighted to see the proposals outlined by the Welsh government to develop a model which will enable PrEP to be provided by community pharmacies
across Wales.
"PrEP are highly effective medicines, that reduce the chances of getting HIV, as proven by the Welsh Government's three year PrEPARED study which found no new
diagnoses of HIV among over 1,200 people taking PrEP in Wales. This is clear evidence that PrEP should be made as easily accessible as possible to those who need it.
"I dread the day, the accountant turns to me and says 'this isn't working' - as an owner, we shelter our patients and teams from the financial pressures
we feel on a daily basis," shares S.G Barai Pharmacy owner, Reena Barai.
Today, S.G Barai Pharmacy in Sutton, Surrey joined pharmacies nationwide in the #SaveOurPharmacies day of action, organised by the National Pharmacy Association
(NPA) to spotlight the critical funding crisis facing community pharmacies across the UK.
Recent figures reveal that over the past decade, more than 1,400 pharmacies have closed in England, Wales, and Northern Ireland, with additional closures looming
in Scotland due to financial pressures.
The NPA reports that three-quarters of pharmacies are operating at a loss, exacerbated by real-terms cuts to funding.
"We turned our lights off and wore black today to symbolize the precarious situation pharmacies like ours are facing," said Reena Barai who owns the pharmacy.
Knights Pharmacy has significantly expanded its footprint in South Wales through its recent acquisition of pharmacies in Abercarn and Cwmcarn from the Evans
Group.
This move marks another strategic expansion for the Redditch-based pharmacy group, bolstered by funding from HSBC UK.
The Abercarn site, which handles approximately 12,000 medication items annually, and the Cwmcarn site, dispensing around 5,000 items, will now operate under the
Knights Pharmacy banner.
This acquisition adds to Knights Pharmacy's growing portfolio, which now spans 49 community sites across England and Wales, a substantial increase from 18 sites
just three years ago.
The Digital Medicines Transformation Portfolio (DMTP) was able to deliver the electronic prescription service (EPS) in Wales - just 20 months after
starting the project - with support from key partners in the NHS and industry.
Patients in Rhyl were the first to benefit from the new service, which allows GPs to send prescriptions electronically to the patient's choice of community
pharmacy, without the need for a paper form.
The new EPS service is currently in a live testing phase, with a phased roll out across Wales expected from January 2024.
DMTP, which is hosted by Digital Health and Care Wales (DHCW) has worked closely with NHS England, who provided the core EPS platform that has been developed
for use in Wales. NHS Wales Shared Services Partnership has also made a major contribution in the project, incorporating digital reimbursement to pharmacies
and putting security measures in place.
In its response to a Freedom of Information Request (FOI), the NHS Business Services Authority (NHSBSA) has confirmed a net decrease of 101 pharmacies
in England - with 371 closures and 270 new contracts. Meanwhile, the General Pharmaceutical Council data projected a drop of 43 registered pharmacies in England,
Wales, and Scotland for the year ending March 31, 2023, compared to the preceding period.
The data, released by business advisor Christie & Co in its annual pharmacy market review on Sept. 5, revealed a total of 14,328 pharmacies across all four UK
country regions as of March 31, 2023, indicating a 0.3 per cent decrease from the previous year. Corporate operators experienced a net reduction of 249 pharmacies,
while the total number of independent operators remained consistent with 2022.
According to the study, the corporate sector saw the most substantial shift, with a 13.7 per cent reduction in businesses operating 300 or more pharmacies.
Following closely, groups managing 11 to 15 pharmacies experienced a 5.6 per cent decrease. Christie & Co attributed this shift in group size to operators
acquiring additional pharmacies through corporate disposal opportunities throughout the year.
Lloyds Pharmacy announced the withdrawal of pharmacy services from all Sainsbury's stores over mounting "industry pressures" faced by the community pharmacies.
The company had 77 branches at the beginning of this year - out of which five branches closed their doors and transferred the ownership of the remaining 72 to others.
It was announced in June this year that Lloyds Pharmacy branches in Sainsbury's will close its operation throughout 2023.
The following decision came after "changing market conditions" put 2,000 jobs on the line across the UK.
Four Lloyds Pharmacies inside Wales Sainsbury's stores closed within days of the announcement and one in the Roath suburb of Cardiff as well.
The remaining 72 changed hands as confirmed by the figures obtained by WalesOnline on 5 October.
The hybrid professional and leadership session underscores the Sigma Conference's significance in offering hope and inspiration to its delegates. This
pioneering venture unfolds following meticulous planning, months of deliberation, and the collaboration of experts from various health disciplines across the UK.
This session, rich in diversity and expertise, aims to elevate the role of community pharmacy in the ever-evolving landscape of the NHS.
It comprises three key components and delves into multi-professional collaboration, insights from NHS Chief Professional Officers from the four devolved nations
complimented by the Royal College of Nursing Directorate Wales, and the evolving landscape of Pharmacy Professional Leadership.
Multi-Professional Collaboration: Breaking Boundaries
The crux of this ground-breaking session lies in appreciating and fostering greater multi-professional collaboration to set the stage for a thought-provoking
session on how community pharmacy can be recognised as an important cog in the wheel of an integrated NHS. This convergence creates a dynamic platform for community
pharmacy to form wider partnerships and explore opportunities, particularly with the recently launched NHS Pharmacy First Service.
To support NHS, clear the backlog created by the Covid-19 pandemic and help community pharmacies support more people, the Welsh government has announced an allocation of further £12.5 million funding.
Of the total amount, £10mn will be distributed across the 22 local authorities to buy equipment to help people to live independently in their own homes post hospital stay.
The remainder, £2.5mn, will be used to support community pharmacists and patients to improve access to treatment and advice for a range of common ailments.
The move is aimed at alleviating waiting times and reducing winter pressures on the NHS.
Commenting on the announcement, Elen Jones, Royal Pharmaceutical Society director for Wales said: "We are delighted that the Welsh government continue to recognise the value of pharmacists in patient care and we welcome this additional investment and support for Community Pharmacy teams across Wales.
The Association of Independent Multiple Pharmacies (AIMp) has changed its name to the Independent Pharmacies Association (IPA).
AIMp, now IPA, stated that rebranding was prompted by the demand from independent community pharmacists for an association that properly represents their interests.
The membership of the Independent Pharmacies Association will not be restricted to pharmacy owners with multiple branches, as was the case with AIMp, but will
be open to all independents, it announced today (Tuesday).
It believes that the switch will "provide a clearer identity and afford a strong voice to the thousands of independent pharmacies in England and Wales."
Furthermore, the IPA noted that it will not primarily function as an insurance organisation with membership attached, but it will be "fighting for and
representing its members across all fronts."
The Welsh chapter of the Royal Pharmaceutical Society, along with ten other royal colleges and professional bodies, have renewed calls for the urgent
transformation of mental health services to address increasing demands on the NHS in Wales.
Representatives of the Royal College Mental Health Expert Advisory Group joined members of the Senedd in Cardiff to outline the work of the group over the past
year and to explain why a well-trained, fully supported and equipped multi-disciplinary workforce is critical for the development of care for people with mental
health conditions.
To make sustainable change happen, the group is calling for a greater focus by the Welsh government and NHS Wales on the following:
The critical changes needed to improve the delivery and structure of mental health services across Wales in community, hospital and specialist secure settings.
Parity of access to mental health services for the most vulnerable patients, ensuring they have equal access opportunities that vulnerable patients would receive for
physical health conditions.
Wales launched the new electronic prescribing service (EPS) last week, with the country's first electronic prescription sent and dispensed on 17 November.
The new service allows prescriptions to be sent digitally to a patient's nominated pharmacy, thus eliminating the need for paper forms.
It is part of a wider plan to introduce digital medicines and e-prescribing in all hospitals and primary care in the country.
Wellington Road Pharmacy and Lakeside Medical Centre in Rhyl became the first community pharmacy and GP practice to use the EPS, which is expected to be
rolled out across Wales in January 2024.
The Royal Pharmaceutical Society (RPS) has introduced a new comprehensive learning programme to support pharmacists in Wales to deliver the Pharmacy
Independent Prescribing Service (PIPS).
Developed in collaboration with Health Education and Improvement Wales (HEIW), the programme is designed to "equip pharmacists with the essential knowledge,
skills, and confidence needed to provide excellent patient care."
While the primary emphasis is on pharmacists operating within primary care settings, those from various practice settings are also encouraged to register and
participate in the programme.
Commenting on the collaboration with HEIW, Elen Jones, director for Wales at the Royal Pharmaceutical Society, said that it will empower pharmacists across the
country to deliver high-quality prescribing services to local communities.
Three UK pharmacists are featured in the digital book of celebrations to mark the International Federation of Pharmacists' (FIP) World Pharmacists' Day 2022.
Simon Nelson, Nelsons Pharmacy Group, Wales; Raj Rohilla, Midhurst Pharmacy (West Sussex)/Goys Pharmacy (Battersea)/ Hamlins Pharmacy (Shepherds Bush) and Olutayo
Arikawe, Swinford Pharmacy, West Midlands were among 27 pharmacists from across the globe and the AmerisourceBergen family, who contributed to a digital book of
celebration, which aims to highlight the changing role of pharmacists and how they can create healthier futures.
Pharmacists are no longer just 'chemists' - some pharmacists are now able to diagnose, treat and prescribe for patients who traditionally may have needed to see a
doctor or GP. Others are guardians of their local community - keeping an eye on vulnerable patients who may not have regular contact with other healthcare
professionals.
During the Covid-19 pandemic they stepped up to support stretched healthcare systems, with many taking a leading role in the world-wide response. This has evolved
further with more and more pharmacists offering vaccination services for Covid-19, as well as flu, chicken pox and 'holiday' vaccinations. This changing role of
pharmacists is helping them unite to create healthier futures.
Paul Rees MBE has joined the National Pharmacy Association (NPA) today (27 November) as its new Chief Executive.
Current NPA Chief Executive Mark Lyonette, who is retiring, will remain at the NPA for some weeks in order to ensure a smooth handover.
Previously, Paul has worked as the Chief Executive of the Royal College of Psychiatrists for the seven years.
On joining NPA, Paul said: "It is a great privilege and honour to take up the position of NPA Chief Executive. The association is the voice of independent
community pharmacy and is core to the sector's future success in England, Scotland, Wales and Northern Ireland.
"I am delighted that the NPA has placed its trust in me and I intend to deliver for NPA members, for the sector and for society at large, which relies on there
being a vibrant community pharmacy network in villages, towns and cities across the four nations of the UK."
When Paul's appointment was first announced in September, NPA Chair Nick Kaye said that they identified him as an "excellent fit for our organisation" after a
rigorous recruitment process, and also thanked Mark for his "great work as chief exec since 2018."
The pharmacy chain has already announced plans to permanently close hundreds of its branches across the UK to consolidate its portfolio of 2,200 stores to 1,900.
Two of its branches in North Wales will be closed next year, with its site in Rhos on Sea set to close its doors in March 2024 and the shop in Colywn Bay the
following month.
In a statement obtained by The Sun, Clwyd West MP David Jones has branded the closures "hugely bad news for the local community".
He added that it is not "a case of simple shop closures," but "another body blow for the local retail economy."
The Station Road shopping centre, where the Colwyn Bay store is located, has already seen the closure of several other prominent stores, including WHSmith, the MP
stated.
The closure of two Boots stores will leave many people "extremely worried as to how they will be able to obtain essential medicines," he added.
Health secretary Sajid Javid said on Monday (December 6) there is now community transmission of the Omicron variant of the coronavirus across regions of England but it is too early to say if this will "knock us off our road to recovery".
Defending the introduction of stricter rules to slow the spread of the virus, Javid told parliament that the government was "leaving nothing to chance" while scientists assessed the variant, which was first reported in South Africa last month.
Javid said there are now 261 Omicron cases in England, 71 in Scotland and four in Wales - a total of 336.
"This includes cases with no links to international travel, so we can conclude there is now community transmission across multiple regions of England," Javid said.
Prime minister Boris Johnson said on Monday no further restrictions were currently needed to deal with the Omicron variant, but refused to rule out imposing such measures before Christmas.
The Royal Pharmaceutical Society (RPS) has published a new professional guidance for prescribing practice on Monday (June 6) which it says will be "for the
benefit of all independent prescribers across the UK".
Based on collaboration with multi-professional stakeholders, the document is a guidance tool for prescribers wanting to expand their prescribing scope of practice.
Commissioned by the Welsh government, the document was developed through an expert group with representatives from many healthcare professions, including from Higher Education institutions, professional bodies, regulatory bodies, the National Institute for Health and Care Excellence, NHS Education for Scotland, Health Education
and Improvement Wales, and representatives from hospital, community and GP practice.
RPS president Claire Anderson said: "It's fantastic to see the growth in prescribing, both across the profession and more widely, to improve patient care.